DNA-Repair Defects and Olaparib in Metastatic Prostate CancerJoaquı́n Mateo, Emma Hall, Johann S. de Bono et al.|New England Journal of Medicine|2015Cited by 2.2k
Integrative Clinical Genomics of Advanced Prostate CancerDan R. Robinson, Susana Miranda, Jake Vinson et al.|Cell|2015Cited by 576
CDK12 loss drives prostate cancer progression, transcription-replication conflicts, and synthetic lethality with paralog CDK13Jean C. Tien, Arul M. Chinnaiyan, Jie Luo et al.|Cell Reports Medicine|2024Cited by 28
<i>CDK12</i> Loss Promotes Prostate Cancer Development While Exposing Vulnerabilities to Paralog-Based Synthetic LethalityJean C. Tien, Arul M. Chinnaiyan, Yu Chang et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 1
A comprehensive proteogenomic analysis of uterine cancerMatthew L. Anderson, T. Liu, Li Ding et al.|Gynecologic Oncology|2019Cited by 0